Perspective Therapeutics (CATX) Liabilities from Discontinued Operations (2022 - 2024)
Perspective Therapeutics (CATX) has disclosed Liabilities from Discontinued Operations for 3 consecutive years, with 5070000.0 as the latest value for Q1 2024.
- Quarterly Liabilities from Discontinued Operations changed N/A to 5070000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was 5070000.0 through Mar 2024, changed N/A year-over-year, with the annual reading at 5072000.0 for FY2023, 1432.33% up from the prior year.
- Liabilities from Discontinued Operations hit 5070000.0 in Q1 2024 for Perspective Therapeutics, roughly flat from 5072000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 5072000.0 in Q4 2023 to a low of 331000.0 in Q4 2022.
- Historically, Liabilities from Discontinued Operations has averaged 3491000.0 across 3 years, with a median of 5070000.0 in 2024.
- Biggest YoY gain for Liabilities from Discontinued Operations was 1432.33% in 2023; the steepest drop was 1432.33% in 2023.
- Year by year, Liabilities from Discontinued Operations stood at 331000.0 in 2022, then soared by 1432.33% to 5072000.0 in 2023, then fell by 0.04% to 5070000.0 in 2024.
- Business Quant data shows Liabilities from Discontinued Operations for CATX at 5070000.0 in Q1 2024, 5072000.0 in Q4 2023, and 331000.0 in Q4 2022.